InvVax Overview

  • Founded
  • 2012
  • Status
  • Private
  • Employees
  • 4
  • Latest Deal Type
  • Series A
  • (Cancelled)
  • Investors
  • 4

InvVax General Information


Developer of vaccine technology designed to develop breakthrough and patented vaccines. The company's technology provides a universal influenza vaccine targeted at preventing virus mutations, enabling physicians to provide efficient prevention from viral diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • Pasadena Bioscience Collaborative
  • 2265 East Foothill Boulevard
  • Pasadena, CA 91107
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

InvVax Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series A) 23-Oct-2018 Cancelled Generating Revenue
3. Accelerator/Incubator 00000 Completed Generating Revenue
2. Seed Round 27-Nov-2018 $240K $615K 00.000 Completed Generating Revenue
1. Seed Round 01-May-2015 $375K $375K 00.000 Completed Generating Revenue
To view InvVax’s complete valuation and funding history, request access »

InvVax Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed-2 0,000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Seed 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
To view InvVax’s complete cap table history, request access »

InvVax Executive Team (4)

Name Title Board Seat Contact Info
Arthur Young Ph.D President and Co-Founder
Matthew Richter-Sand Co-Founder and Board Member
Jonathan Lasch Ph.D Advisor
You’re viewing 3 of 4 executive team members. Get the full list »

InvVax Board Members (5)

Name Representing Role Since
Matthew Richter-Sand InvVax Co-Founder and Board Member 000 0000
Olga Petrauskene Ph.D Self Board Member 000 0000
Paul Swartz Ph.D Self Board Member 000 0000
Todd Patrick Self Board Member 000 0000
Tyler Tarr Self Board Member 000 0000
To view InvVax’s complete board members history, request access »

InvVax Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

InvVax Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Crescent Ridge Partners Venture Capital Minority 000 0000 000000 0
Life Science Angels Angel Group Minority 000 0000 000000 0
Tech Coast Angels Angel Group Minority 000 0000 000000 0
UCLA CNSI Incubator Accelerator/Incubator 000 0000 000000 0
To view InvVax’s complete investors history, request access »